BIOMED RES INT 润色咨询

Biomed Research International

出版年份:暂无数据 年文章数:2188 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:2.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2023-03-21 woshiliwj 来自浙江省

    这个杂志被踢出sci了!

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2023-03-21 ms6000002114457146

    小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2023-03-26 ms2000002146747069 来自四川省

    这个杂志在wos还能检索到吗

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2023-03-22 Drwurh 来自广东省

    偏重的研究方向:神经科学;免疫
    经验分享:已被踢sci了,感觉撤稿重投了

    10

    展开10条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2022-11-23 ms4000001680289394

    偏重的研究方向:生物信息学;药效学及机制研究
    经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2023-02-12 LCXXXX 来自黑龙江省

    投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2021-12-31 1defd82cm50(暂无匿称)

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;生物信息
    经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2022-10-29 ms9000001657033209

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:药理
    经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业

    7

    展开7条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2020-07-01 mysteriousperfume

    审稿速度:2.0 | 投稿命中率:75.0
    经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2120894, encodeId=29af2120894d4, content=这个杂志被踢出sci了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Mar 21 21:33:07 CST 2023, time=2023-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2120913, encodeId=8e0e21209139c, content=小修修回,结果这本期刊被踢出sci了,怎么办,撤稿么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0278145464, createdName=ms6000002114457146, createdTime=Tue Mar 21 22:55:53 CST 2023, time=2023-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121991, encodeId=cfb2212199155, content=这个杂志在wos还能检索到吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9d95692568, createdName=ms2000002146747069, createdTime=Sun Mar 26 23:55:12 CST 2023, time=2023-03-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2121232, encodeId=19c42121232bb, content=偏重的研究方向:神经科学;免疫<br>经验分享:已被踢sci了,感觉撤稿重投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/30/1326c8f87cd23d5cadb97642c4d850bc.jpg, createdBy=b47b2366269, createdName=Drwurh, createdTime=Wed Mar 22 23:41:31 CST 2023, time=2023-03-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2102140, encodeId=dd0e2102140fc, content=偏重的研究方向:生物信息学;药效学及机制研究<br>经验分享: 9-9 Submit 9-22 Under review 9-29 Pending approval 10-5 Submit revision 11-11 Under review (个人原因,修改稿上传的晚一些) 11-17 Pending approval 11-23 Accepted 投本杂志的第二篇。 第一篇前后花了4个月的时间才录用。第二篇 花了2月左右的时间,除了个人原因 耽误了一段时间。总体来讲,第二篇比较顺利。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Wed Nov 23 09:38:48 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114221, encodeId=7ad72114221b4, content=投了8天了,还在s u b m i t t e d,S E和A E都是u n a s s i g n e d状态,大家多久能进行到下一步??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLibA6fR6r7UBcywPX2ib4qynVzBf91GEBflgqjmYLicW2bt9t99TsSXf8iaLmYjXORutvzeRZd9LoPJQ/132, createdBy=2d692442768, createdName=LCXXXX, createdTime=Sun Feb 12 13:03:23 CST 2023, time=2023-02-12, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1179256, encodeId=cae111e925699, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;生物信息<br>经验分享:研究方向:肿瘤的生物信息学 2021-05-02投稿 2021-09-14收到审稿意见,大修 2021-10-13修回 2021-12-22接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e311736657, createdName=1defd82cm50(暂无匿称), createdTime=Fri Dec 31 13:09:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097346, encodeId=7d51209e346dc, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:药理<br>经验分享:大家pending approval大概多久,我已经半个月了,会不会被拒稿,着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f66513648, createdName=ms9000001657033209, createdTime=Sat Oct 29 20:08:54 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800786, encodeId=7c0a800e8695, content=审稿速度:2.0 | 投稿命中率:75.0<br>经验分享:连续被好几个三分多的杂志拒稿,有这个杂志,小修,二个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b091317808, createdName=mysteriousperfume, createdTime=Wed Jul 01 16:03:37 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120834, encodeId=da2d2120834aa, content=踢出scie了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57d5450113, createdName=ms4000002019232997, createdTime=Tue Mar 21 18:29:25 CST 2023, time=2023-03-21, status=1, ipAttribution=湖北省)]
    2023-03-21 ms4000002019232997 来自湖北省

    踢出scie了

    0

共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分